Journal profile · Medicine-Pathology and Forensic Medicine
Journal of Pathology Clinical Research
ISSN 2056-4538 · Wiley-Blackwell · ENGLAND
Journal of Pathology Clinical Research: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.08; fully open access; APC about USD 3,570; median 106 days to acceptance (86 articles, last 24 months); acceptance rate 16% (journal website); 69 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Pathology Clinical Research is published by Wiley-Blackwell and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Genomics and Diagnostics, Diverse Scientific and Economic Studies and Human auditory perception and evaluation, together about 22.6% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Pathology: Clinical Research and The Journal of Pathology serve as translational bridges between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The focus of The Journal of Pathology: Clinical Research is the publication of studies that illuminate the clinical relevance of research in the broad area of the study of disease. Appropriately powered and validated studies with novel diagnostic, prognostic and predictive significance, and biomarker discover and validation, will be welcomed. Studies with a predominantly mechanistic basis will be more appropriate for the companion Journal of Pathology. The Journal welcomes investigative diagnostic, prognostic, and biomarker studies with clear clinical relevance, that advance our understanding of the mechanisms of human disease. In general, hypothesis-driven studies that are appropriately powered and validated will be preferred. As well as original research papers, the Journal seeks to provide rapid publication in a variety of other formats, including editorials, review articles, commentaries and perspectives and other features, both contributed and solicited. In all cases, contributions are subjected to strict peer review. Purely descriptive papers (including case reports and new diagnostic techniques) that do not provide novel insights into clinical disease are not considered central to the Journal’s purpose.Correspondence relating to papers published in the Journal will be considered, but only if of general interest. In determining content, the primary considerations are excellence, relevance and novelty. As a journal of The Pathological Society, it seeks to reflect the broad scientific interests of the Society’s membership but its ethos, authorship, content and purpose are those expected of a leading publication in the international scientific literature. Abstracting and Indexing Information CAS: Chemical Abstracts Service (ACS) Embase (Elsevier) Emerging Sources Citation Index (Clarivate Analytics) Web of Science (Clarivate Analytics)
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pathology and Forensic Medicine
Editor-in-chief C SimonPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 3, Germany 2 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology8.4%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance7.1%
- Human auditory perception and evaluationEngineering7.1%
- Educational Robotics and EngineeringComputer Science7.1%
- Cancer Immunotherapy and BiomarkersMedicine6.9%
- Genetic factors in colorectal cancerMedicine5.7%
- AI in cancer detectionComputer Science4.9%
- Cancer Cells and MetastasisMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ESCIWeb of SciencePubMedEmbaseCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.08LetPub ·
- Impact factor (publisher)
- 4.1Publisher website ·
- Impact factor (publisher) 2025
- 4.1Publisher website ·
- CiteScore 2026-06
- 7.3LetPub ·
- CiteScore (publisher)
- 7.3Publisher website ·
- CiteScore (publisher) 2025
- 7.3Publisher website ·
- SJR 2026-06
- 1.36LetPub ·
- SNIP 2026-06
- 0.99LetPub ·
- h-index
- 50OpenAlex ·
- i10-index
- 257OpenAlex ·
- 2-year mean citedness
- 3.33OpenAlex ·
- Self-citation rate
- 4.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 47LetPub ·
- Articles per year (publisher) 2025
- 57Publisher website ·
- Downloads per year (publisher) 2025
- 170,807Publisher website ·
Articles by year OpenAlex count · 563 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 45 | 45 | 24 |
| 2025 | 69 | 69 | 142 |
| 2024 | 58 | 58 | 406 |
| 2023 | 51 | 51 | 537 |
| 2022 | 54 | 54 | 760 |
| 2021 | 66 | 66 | 1,215 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
106 daysMedian, submission to acceptance · P25–P75 67 days – 151 days
- Acceptance to online
- median 22 days (86 articles)
- Submission to online
- median 137 days
- Sample
- 86 articles with submission and acceptance dates (117 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 20 weeksLetPub ·
- Acceptance rate (publisher)
- 16%Publisher website ·
- Acceptance rate (publisher) 2025
- 16%Publisher website ·
- Submission to first decision
- 4 daysPublisher website ·
- Submission to first decision 2025
- 4 daysPublisher website ·
- Submission to acceptance 2025
- 91 daysPublisher website ·
- Acceptance to publication 2025
- 24 daysPublisher website ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,570 / GBP 2,520 / EUR 3,240 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 3,250 / EUR 2,950 / GBP 2,290 | — | — | |
| LetPub | USD 2,810 / GBP 1,980 / EUR 2,550 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- ≥ 3
- Manuscript length
- ≤ 4,000 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional, 5
Article types accepted6, with length limits
- brief definitive reportsBrief Definitive Reports Brief Definitive Reports provide a forum for the rapid publication of highly significant and timely advances. They are up to 1500 words…Length not stated
- commentariesCommentaries Brief reviews placing recently published primary research from the Journal into context. These are usually less than 2000 words.Length not stated
- full articleelayed by editing to a suitable length. Full articles should be no more than 4000 words from the beginning of the Introduction to the end of the Dimain text ≤ 4,000 words
- in briefIn Brief Mini-reviews highlighting topical subjects. These are usually invited but suggestions are welcomed. Typically 1000 wordsLength not stated
- original articlesOriginal Articles Original articles are our mian type of primary publication. They are up to 4000 words in length from beginning of Introduction to end of Discu…Length not stated
- perspectivesPerspectives Overview articles highlighting novel, debatable, or highly topical aspects of pathology research. These are usally less than 2000 words.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, Open access, Peer review, Plagiarism
- Authorship 4.17 Statement of author contributions
A statement outlining the specific contribution of each author to the manuscript and the work reported in it must appear (e.g. study design, data collection, data analysis, data interpretation, literature search, generation of figures, writing of the manuscript). If all authors contributed equally, please say so. Our preferred style is: ABC and EF conceived and carried out experiments; JKL and PQ …
Source ↗Publisher website ·- Conflicts of interest 4.7 Conflict of interest statements
Authors must disclose all financial and personal relationships that might bias their work; to prevent ambiguity, a conflict of interest statement must appear on the manuscript title page, detailing any conflicts (or the absence thereof) for each author An Editorial on this subject was published in the Journal of Pathology and the same principles apply to papers published in the Journal of Patholog…
Source ↗Publisher website ·- Publication ethics 4.34 COPE
As a member of the Committee on Publication Ethics (COPE), adherence to these submission criteria is considered essential for publication in The Journal of Pathology; mandatory fields are included in the online submission process to ensure this. If, at a later stage in the submission process or even after publication, a manuscript or authors are found to have disregarded these criteria, it is the …
Source ↗Publisher website ·- Open access 4.26 Open Access Agreement
Once your paper is accepted, the corresponding author will be presented with the option to sign an open access agreement (on behalf of all co-authors) to make the article available under the terms of either the Creative Commons Attribution Non-Commercial (CC-BY-NC) license or the Creative Commons Attribution-Non-Commercial-NoDerivs License (CC-BY-NC-ND). From the 1st of April 2013 RCUK or Wellcome…
Source ↗Publisher website ·- Peer review 2 THE REVIEW PROCESS
Authors may suggest up to five referees; may object to named individuals Model summary
The Editorial processes are identical to those for the Journal of Pathology. For further detail, please see this Editorial: A guide to the Editorial processes at The Journal of Pathology. J Pathol 2009;142:1-6.) On receipt, manuscripts are assessed by the Editor-in-Chief, a Senior Editor and at least one Associate Editor. At this point, those outside our scope or quality criteria are returned to t…
Source ↗Publisher website ·- Plagiarism
Plagiarism screening with iThenticate Model summary
A similarity search engine (iThenticate®) is used to detect plagiarism and duplicate publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 2056-4538
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Pathology Clinical Research
What CAS zone is Journal of Pathology Clinical Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pathology Clinical Research is in Zone 2 of Medicine, and in Zone 2 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Pathology Clinical Research?
The latest impact factor listed by LetPub is 4.08; CiteScore 7.3, h-index 50.
How long does peer review take at Journal of Pathology Clinical Research?
Based on the dates recorded on 86 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 106 days (interquartile range 67–151 days); authors report an average review time of about 20 weeks; the journal's website gives an acceptance rate of 16% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Pathology Clinical Research?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: ≥ 3; Manuscript length: ≤ 4,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional, 5. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Pathology Clinical Research based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (3) and Germany (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Pathology Clinical Research?
According to LetPub and DOAJ records, Journal of Pathology Clinical Research is indexed in SCIE, Scopus and DOAJ. The journal's website also lists ESCI, Web of Science, PubMed, Embase and CAS; that list has not been checked against each database.
Is Journal of Pathology Clinical Research open access, and what is the APC?
Journal of Pathology Clinical Research is a fully open-access journal. APC about USD 3,570.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .